logo

For the Inventor, By the Inventor

Lake Villa, IL, United States of America

Frank S Ungemach

USPTO Granted Patents = 10

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 105(Granted Patents)


Location History:

  • Wadsworth, IL (US) (1995)
  • Lake Villa, IL (US) (1992 - 1996)

Company Filing History:

goldMedal10 out of 4,179 
 
Abbott Laboratories Corporation
 patents

Years Active: 1992-1996

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5501985 - Analyte-substitute reagent for use in specific binding assay methods, (1996-03-26),
2. 5463027 - Fluorescence polarazation immunoassay for tetrahydrocannabinoids (1995-10-31),
3. 5407834 - Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, (1995-04-18),
4. 5340748 - Analyte-substitute reagent for use in specific binding assay methods, (1994-08-23),
5. 5264373 - Fluorescence polarization immunoassay for tetrahydrocannabinoids (1993-11-23),
6. 5221629 - Phencyclidine and phencyclidine metabolites assay, tracers, immunogens (1993-06-22),
7. 5202270 - Cocaine and cocaine metabolites assay tracers, immunogens and antibodies (1993-04-13),
8. 5155212 - Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, (1992-10-13),
9. 5144030 - Fluorescene polarization immunoassay for tetrahydrocannabinoids (1992-09-01),
10. 5124457 - Phencyclidine and phencyclidine metabolites assay, tracers, immunogens (1992-06-23),

Title: Frank S. Ungemach: Innovator in Assay Technologies

Introduction

Frank S. Ungemach is a notable inventor based in Lake Villa, IL (US). He has made significant contributions to the field of assay technologies, holding a total of 10 patents. His work primarily focuses on developing innovative methods and reagents for analyzing low molecular weight analytes.

Latest Patents

Among his latest patents, one includes an analyte-substitute reagent for use in specific binding assay methods. This invention involves the use of an analyte-substitute reagent (ASR) comprising at least two components. The first component is identical to or an analog of the analyte to be determined, while the second is an unrelated ligand for which an antibody or other specific binding member can be obtained or produced. Another significant patent is related to a fluorescence polarization immunoassay for tetrahydrocannabinoids (THC). This disclosure pertains to a method and reagents for determining THC and its metabolites in biological fluids such as urine. The procedure described also provides for a novel wash reagent for a THC fluorescence polarization assay.

Career Highlights

Frank S. Ungemach is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the field of assay technologies. His work has been instrumental in advancing methods for analyzing complex biological samples.

Collaborations

He has collaborated with notable colleagues, including Robert E. Dubler and Daniel S. Nam, contributing to the development of cutting-edge assay technologies.

Conclusion

Frank S. Ungemach's contributions to assay technologies have significantly impacted the field, showcasing his innovative spirit and dedication to advancing scientific research. His patents reflect a commitment to improving methods for analyzing low molecular weight analytes, making him a key figure in this area of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…